Generic Name and Formulations:
Isosulfan blue 10mg/mL; soln for SC inj; preservative-free.
Indications for LYMPHAZURIN:
An adjunct to lymphography (in primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities) for visualization of the lymphatic system draining the region of injection.
Give by SC inj. 0.5mL into 3 interdigital spaces of each extremity per study. Max dose 3mL (30mg).
Hypersensitivity to triphenylmethane.
Have emergency equipment available for at least 30–60 minutes after injection. Urine color may be blue for 24hrs post administration. Pregnancy (Cat.C). Nursing mothers.
Do not mix with local anesthetics (eg, lidocaine) in the same syringe; precipitation results.
Local reactions, pruritus; anaphylaxis possible.
Single-dose vial (5mL)—1
Psychiatry Advisor Articles
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments
- Increase Use of Nursing Home for Patients With Cognitive Impairment Category
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder